Use este identificador para citar ou linkar para este item: http://repositorio.bc.ufg.br/handle/ri/14263
Tipo do documento: Artigo
Título: International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients
Autor: Schijman, Alejandro Gabriel
Bisio, Margarita
Orellana, Liliana
Sued, Mariela
Duffy, Tomás
Jaramillo, Ana Maria Mejia
Cura, Carolina
Auter, Frederic
Veron, Vincent
Qvarnstrom, Yvonne
Deborggraeve, Stijn
Hijar, Gisely
Zulantay, Inés
Lucero, Raúl Horacio
Velazquez, Elsa
Tellez, Tatiana
Leon, Zunilda Sanchez
Galvão, Lucia
Nolder, Debbie
Rumi, María Monje
Levi, José Eduardo
Ramirez, Juan David
Zorrilla, Pilar
Flores, María
Jercic, Maria Isabel
Crisante, Gladys
Añez, Néstor
Castro, Ana Maria de
Gonzalez, Clara Isabel
Viana, Karla Acosta
Yachelini, Pedro
Torrico, Faustino
Robello, Carlos
Diosque, Patricio
Chavez, Omar Triana
Aznar, Christine
Russomando, Graciela
Büscher, Philippe
Assal, Azzedine
Guhl, Felipe
Estani, Sergio Sosa
DaSilva, Alexandre
Britto, Constança
Ostermayer, Alejandro Luquetti
Ladzins, Janis
Abstract: Background: A century after its discovery, Chagas disease still represents a major neglected tropical threat. Accurate diagnostics tools as well as surrogate markers of parasitological response to treatment are research priorities in the field. The purpose of this study was to evaluate the performance of PCR methods in detection of Trypanosoma cruzi DNA by an external quality evaluation. Methodology/Findings: An international collaborative study was launched by expert PCR laboratories from 16 countries. Currently used strategies were challenged against serial dilutions of purified DNA from stocks representing T. cruzi discrete typing units (DTU) I, IV and VI (set A), human blood spiked with parasite cells (set B) and Guanidine Hidrochloride-EDTA blood samples from 32 seropositive and 10 seronegative patients from Southern Cone countries (set C). Forty eight PCR tests were reported for set A and 44 for sets B and C; 28 targeted minicircle DNA (kDNA), 13 satellite DNA (Sat-DNA) and the remainder low copy number sequences. In set A, commercial master mixes and Sat-DNA Real Time PCR showed better specificity, but kDNA-PCR was more sensitive to detect DTU I DNA. In set B, commercial DNA extraction kits presented better specificity than solvent extraction protocols. Sat-DNA PCR tests had higher specificity, with sensitivities of 0.05–0.5 parasites/ mL whereas specific kDNA tests detected 5.1023 par/mL. Sixteen specific and coherent methods had a Good Performance in both sets A and B (10 fg/ml of DNA from all stocks, 5 par/mL spiked blood). The median values of sensitivities, specificities and accuracies obtained in testing the Set C samples with the 16 tests determined to be good performing by analyzing Sets A and B samples varied considerably. Out of them, four methods depicted the best performing parameters in all three sets of samples, detecting at least 10 fg/ml for each DNA stock, 0.5 par/mL and a sensitivity between 83.3–94.4%, specificity of 85–95%, accuracy of 86.8–89.5% and kappa index of 0.7–0.8 compared to consensus PCR reports of the 16 good performing tests and 63–69%, 100%, 71.4–76.2% and 0.4–0.5, respectively compared to serodiagnosis. Method LbD2 used solvent extraction followed by Sybr-Green based Real time PCR targeted to Sat-DNA; method LbD3 used solvent DNA extraction followed by conventional PCR targeted to Sat-DNA. The third method (LbF1) used glass fiber column based DNA extraction followed by TaqMan Real Time PCR targeted to Sat-DNA (cruzi 1/cruzi 2 and cruzi 3 TaqMan probe) and the fourth method (LbQ) used solvent DNA extraction followed by conventional hot-start PCR targeted to kDNA (primer pairs 121/122). These four methods were further evaluated at the coordinating laboratory in a subset of human blood samples, confirming the performance obtained by the participating laboratories. Conclusion/Significance: This study represents a first crucial step towards international validation of PCR procedures for detection of T. cruzi in human blood samples.
País: Estados unidos
Unidade acadêmica: Instituto de Patologia Tropical e Saúde Pública - IPTSP (RG)
Citação: SCHIJMAN, Alejandro G.; BISIO, Margarita; ORELLANA, Liliana; SUED, Mariela; DUFFY, Tomás; JARAMILLO, Ana M. Mejia; CURA, Carolina; AUSTER, Frederic; VERON, Vincent; QVARNSTROM, Yvonne; DEBORGGRAEVE, Stijn; HIJAR, Gisely; ZULANTAY, Inés; LUCERO, Raúl Horacio; VELAZQUEZ, Elsa; TELLEZ, Tatiana; LEON, Zunilda Sanchez; GALVÃO, Lucia; NOLDER, Debbie; RUMI, María Monje; LEVI, José E.; RAMIREZ, Juan D.; ZORRILA, Pilar; FLORES, María; JERCIC, Maria I.; CRISANTE, Gladys; AÑEZ, Néstor; CASTRO, Ana M. de; GONZALEZ, Clara I.; VIANA, Karla Acosta; YACHELINI, Pedro; TORRICO, Faustino; ROBELLO, Carlos; DIOSQUE, Patricio; CHAVEZ, Omar Triana; AZNAR, Christine; RUSSOMANDO, Graciela; BÜSCHER, Philippe; ASSAL, Azzedine; GUHL, Felipe; ESTANI, Sergio Sosa; DASILVA, Alexandre; BRITTO, Constança; LUQUETTI, Alejandro; LADZINS, Janis. International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients. Plos Neglected Tropical Diseases, San Francisco, v. 5, n. 1, p. e931, Jan. 2011.
Tipo de acesso: Acesso Aberto
Identificador do documento: 10.1371/journal.pntd.0000931
Identificador do documento: 10.1371/journal.pntd.0000931
URI: http://repositorio.bc.ufg.br/handle/ri/14263
Data de publicação: Jan-2011
Aparece nas coleções:FM - Artigos publicados em periódicos

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
Artigo - Alejandro Gabriel Schijman - 2011.pdf864,42 kBAdobe PDFThumbnail
Baixar/Abrir


Este item está licenciada sob uma Licença Creative Commons Creative Commons